1. Home
  2. CCNE vs XERS Comparison

CCNE vs XERS Comparison

Compare CCNE & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCNE
  • XERS
  • Stock Information
  • Founded
  • CCNE 1865
  • XERS 2005
  • Country
  • CCNE United States
  • XERS United States
  • Employees
  • CCNE N/A
  • XERS N/A
  • Industry
  • CCNE Major Banks
  • XERS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCNE Finance
  • XERS Health Care
  • Exchange
  • CCNE Nasdaq
  • XERS Nasdaq
  • Market Cap
  • CCNE 485.2M
  • XERS 444.0M
  • IPO Year
  • CCNE N/A
  • XERS 2018
  • Fundamental
  • Price
  • CCNE $27.63
  • XERS $2.92
  • Analyst Decision
  • CCNE Hold
  • XERS Buy
  • Analyst Count
  • CCNE 1
  • XERS 3
  • Target Price
  • CCNE $22.00
  • XERS $4.87
  • AVG Volume (30 Days)
  • CCNE 60.0K
  • XERS 1.9M
  • Earning Date
  • CCNE 10-21-2024
  • XERS 11-08-2024
  • Dividend Yield
  • CCNE 2.61%
  • XERS N/A
  • EPS Growth
  • CCNE N/A
  • XERS N/A
  • EPS
  • CCNE 2.33
  • XERS N/A
  • Revenue
  • CCNE $216,515,000.00
  • XERS $187,361,000.00
  • Revenue This Year
  • CCNE N/A
  • XERS $20.35
  • Revenue Next Year
  • CCNE $8.80
  • XERS $16.14
  • P/E Ratio
  • CCNE $11.86
  • XERS N/A
  • Revenue Growth
  • CCNE N/A
  • XERS 22.72
  • 52 Week Low
  • CCNE $17.74
  • XERS $1.53
  • 52 Week High
  • CCNE $29.29
  • XERS $3.64
  • Technical
  • Relative Strength Index (RSI)
  • CCNE 59.25
  • XERS 37.78
  • Support Level
  • CCNE $26.76
  • XERS $3.03
  • Resistance Level
  • CCNE $29.03
  • XERS $3.33
  • Average True Range (ATR)
  • CCNE 0.93
  • XERS 0.19
  • MACD
  • CCNE 0.09
  • XERS -0.05
  • Stochastic Oscillator
  • CCNE 65.63
  • XERS 1.37

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. In addition, the corporation provides wealth and asset management services, retirement plans and other employee benefit plans.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.

Share on Social Networks: